Patience David Insider Trades

Insider Trading History

Track insider trading activity for Patience David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Chief Financial Officer
Holding Value $3.13M 275,757 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$80.6k 7,100 shares
$11.35
$11.35
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Chief Financial Officer
Holding Value $877k 275,757 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.3k 7,100 shares
$2.43
$3.18
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Chief Financial Officer
Holding Value $60.1k 275,757 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.55k 7,100 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Chief Financial Officer
Holding Value $854k 268,657 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$18.2k 3,657 shares
$4.99
$3.18
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Chief Financial Officer
Holding Value $3.05M 268,657 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$41.5k 3,657 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Chief Financial Officer
Holding Value $58.6k 268,657 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$797 3,657 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Chief Financial Officer
Holding Value $2.13M 668,899 shares
Last Trade
Nov 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 195,000 shares
$5.55
$3.18
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Chief Financial Officer
Holding Value $7.59M 668,899 shares
Last Trade
Nov 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.21M 195,000 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Chief Financial Officer
Holding Value $146k 668,899 shares
Last Trade
Nov 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 195,000 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Chief Financial Officer
Holding Value $1.71M 538,899 shares
Last Trade
Aug 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 248,899 shares
$5.11
$3.18
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Chief Financial Officer
Holding Value $6.12M 538,899 shares
Last Trade
Aug 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.83M 248,899 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Chief Financial Officer
Holding Value $117k 538,899 shares
Last Trade
Aug 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.3k 248,899 shares
$0.22
$0.22
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Chief Financial Officer
Holding Value $63.2k 290,000 shares
Last Trade
Aug 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.2k 290,000 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Chief Financial Officer
Holding Value $922k 290,000 shares
Last Trade
Aug 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.13M 290,000 shares
$3.88
$3.18
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Chief Financial Officer
Holding Value $3.29M 290,000 shares
Last Trade
Aug 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.29M 290,000 shares
$11.35
$11.35
Accelerate Diagnostics
Accelerate Diagnostics AXDX
Chief Financial Officer
Holding Value $2.2k 64,568 shares
Last Trade
Apr 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.84k 6,816 shares
$0.71
$0.03
Accelerate Diagnostics
Accelerate Diagnostics AXDX
Chief Financial Officer
Holding Value $1.02k 30,000 shares
Last Trade
Apr 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.1k 20,000 shares
$0.71
$0.03
Accelerate Diagnostics
Accelerate Diagnostics AXDX
Chief Financial Officer
Holding Value $2.43k 71,384 shares
Last Trade
Apr 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.1k 20,000 shares
$0.71
$0.03
Accelerate Diagnostics
Accelerate Diagnostics AXDX
Chief Financial Officer
Holding Value $1.77k 51,919 shares
Last Trade
Feb 26, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.59k 1,500 shares
$1.06
$0.03
Accelerate Diagnostics
Accelerate Diagnostics AXDX
Chief Financial Officer
Holding Value $1.75k 51,384 shares
Last Trade
Feb 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$583 535 shares
$1.09
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up